Published: May 22, 2021, 01:50 IST | Updated: May 22, 2021, 01:50 IST
Indian government and Pfizer are at loggerheads over a demand by the US drug maker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets.